These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Effect of a bronchosecretolytic agent on the tracheobronchial expectoration]. Iravani J Arzneimittelforschung; 1972 Oct; 22(10):1744-6. PubMed ID: 4677067 [No Abstract] [Full Text] [Related]
5. Theory and practice of the use of expectorants reviewed from clinical aspects. Nagy G Ther Hung; 1984; 32(1):6-12. PubMed ID: 6400475 [No Abstract] [Full Text] [Related]
6. Mucus-controlling agents: past and present. King M; Rubin BK Respir Care Clin N Am; 1999 Dec; 5(4):575-94. PubMed ID: 10565882 [TBL] [Abstract][Full Text] [Related]
8. [Therapeutic possibilities in chronic non-specific respiratory tract diseases. 1. Modification of secretion, inhalation- and respiration therapy, therapy of bronchial obstruction]. Löllgen H; Löllgen-Horres I; von Nieding G Fortschr Med; 1976 Aug; 94(24):1276-84. PubMed ID: 786833 [No Abstract] [Full Text] [Related]
9. Conference on the scientific basis of respiratory therapy. Aerosol therapy. Introduction. Lourenço RV Am Rev Respir Dis; 1974 Dec; 110(6 Pt 2):85-7. PubMed ID: 4440947 [No Abstract] [Full Text] [Related]
10. [The use of expectorant agents]. Galsanov Shch B Sov Med; 1987; (12):100-5. PubMed ID: 3328304 [No Abstract] [Full Text] [Related]
11. Pharmacological impact on mucociliary clearance. Verstraeten JM Arch Monaldi; 1982; 37(1-2):37-58. PubMed ID: 6765046 [No Abstract] [Full Text] [Related]
12. [Liquefacation of viscous bronchial secretion]. Kurz JF Landarzt; 1968 Oct; 44(29):Suppl:4-13. PubMed ID: 5712713 [No Abstract] [Full Text] [Related]
13. Disturbances in the pattern of secretion of bronchial mucous glands. Reid L Ciba Found Study Group; 1968; 32():45-67. PubMed ID: 5760787 [No Abstract] [Full Text] [Related]
14. [Modifications of the immunoglobulins in bronchial secretions induced by treatment with bromexin and oxytetracycline]. Olivieri D; Bocchino M; Caputi M Arch Monaldi; 1970; 25(6):537-44. PubMed ID: 4105892 [No Abstract] [Full Text] [Related]
15. [Controlled clinical study on the activity of a new mucoregulating drug in obstructive bronchial pathology with a marked hypersecretory feature. The pediatric experience]. Romano C; Gargani GF; Minicucci L; Nantron M Minerva Pediatr; 1984 Feb; 36(3):127-38. PubMed ID: 6374414 [No Abstract] [Full Text] [Related]
16. [Antitussives and expectorants-a review (author's transl)]. Petrin A; Schmidt R Schweiz Rundsch Med Prax; 1974 Jan; 63(2):30-6. PubMed ID: 4605508 [No Abstract] [Full Text] [Related]
20. [The control of bronchial secretions in chronic hypersecretory bronchopneumopathies: the role of letosteine]. Morandini G; Finiguerra M; Fraticelli G; Ferraris F; Gallone F Clin Ter; 1986 Feb; 116(3):179-93. PubMed ID: 3516541 [No Abstract] [Full Text] [Related] [Next] [New Search]